These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 926279

  • 1. Lymphocyte response to transitional cell carcinoma: peripheral cytotoxicity and local tumor infiltration.
    Jones LW, O'Toole C.
    J Urol; 1977 Dec; 118(6):974-7. PubMed ID: 926279
    [Abstract] [Full Text] [Related]

  • 2. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
    Jones LW, O'Toole C.
    Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
    [Abstract] [Full Text] [Related]

  • 3. Lymphocyte cytotoxicity against autologous bladder tumor cells in humans, investigated by use of a chromium-51 release assay.
    Jacobsen F.
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):175-80. PubMed ID: 7315355
    [Abstract] [Full Text] [Related]

  • 4. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
    Troye M, Pape GR.
    Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
    [Abstract] [Full Text] [Related]

  • 5. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
    Perlmann P, Troye M, Pape G, Blomgren H, Johansson B.
    Urol Res; 1978 Dec; 6(4):207-9. PubMed ID: 741533
    [Abstract] [Full Text] [Related]

  • 6. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
    Morales A.
    Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
    [Abstract] [Full Text] [Related]

  • 7. A follow-up study of urinary bladder patients tested for tumour-related lymphocyte-mediated cytotoxicity.
    Larsson A, Näslund I, Troye M.
    Cancer Immunol Immunother; 1982 Dec; 14(2):82-5. PubMed ID: 6965230
    [Abstract] [Full Text] [Related]

  • 8. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD, Makhlin NV.
    Urol Nefrol (Mosk); 1984 Dec; (2):67-70. PubMed ID: 6372193
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lack of specificity of lymphocyte-mediated cytotoxicity against the bladder cancer cell line, T24.
    Catalona WJ, Oldham RK, Herberman RB, Djeu JY, Cannon GB.
    J Urol; 1977 Aug; 118(2):254-7. PubMed ID: 330885
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y, Nio Y, Yoshida O.
    J Urol; 1992 Feb; 147(2):505-10. PubMed ID: 1732632
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.